Could a single infusion of 'Peacekeeper' cells let kidney patients ditch most Anti-Rejection pills?
Disease control
Recruiting now
This study tests a new treatment called TRK-001, made from a patient's own regulatory T cells (immune 'peacekeepers'), to prevent kidney transplant rejection. About 34 adults receiving a living donor kidney will either get standard anti-rejection drugs alone or those drugs plus a…
Phase: PHASE2 • Sponsor: Singulera Therapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC